Renapath

Benzoicum Acidum, Berberis Vulgaris, Bryonia, Dna, Eupatorium Purpureum, Glandula Suprarenalis Suis, Hydrangea Arborescens, Hypothalamus, Mercurius Corrosivus, Pancreas Suis, Pareira Brava, Petroselinum Sativum, Pituitarum Posterium, Rubia Tinctorum, Sarsaparilla, Solidago Virgaurea, Thyroidinum (bovine), Uva-ursi

Energetix Corp
Human Otc Drug
NDC 64578-0103

Renapath also known as Benzoicum Acidum, Berberis Vulgaris, Bryonia, Dna, Eupatorium Purpureum, Glandula Suprarenalis Suis, Hydrangea Arborescens, Hypothalamus, Mercurius Corrosivus, Pancreas Suis, Pareira Brava, Petroselinum Sativum, Pituitarum Posterium, Rubia Tinctorum, Sarsaparilla, Solidago Virgaurea, Thyroidinum (bovine), Uva-ursi is a human otc drug labeled by 'Energetix Corp'. National Drug Code (NDC) number for Renapath is 64578-0103. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Renapath drug includes Arctostaphylos Uva-ursi Leaf - 4 [hp_X]/mL Benzoic Acid - 10 [hp_X]/mL Berberis Vulgaris Root Bark - 4 [hp_X]/mL Bos Taurus Hypothalamus - 12 [hp_X]/mL Bryonia Alba Root - 12 [hp_X]/mL Chondrodendron Tomentosum Root - 10 [hp_X]/mL Eutrochium Purpureum Root - 12 [hp_X]/mL Herring Sperm Dna - 12 [hp_X]/mL Hydrangea Arborescens Root - 4 [hp_X]/mL Mercuric Chloride - 12 [hp_X]/mL and more. The currest status of Renapath drug is Active.

Drug Information:

Drug NDC:	64578-0103
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Renapath
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Benzoicum Acidum, Berberis Vulgaris, Bryonia, Dna, Eupatorium Purpureum, Glandula Suprarenalis Suis, Hydrangea Arborescens, Hypothalamus, Mercurius Corrosivus, Pancreas Suis, Pareira Brava, Petroselinum Sativum, Pituitarum Posterium, Rubia Tinctorum, Sarsaparilla, Solidago Virgaurea, Thyroidinum (bovine), Uva-ursi
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Energetix Corp
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ARCTOSTAPHYLOS UVA-URSI LEAF - 4 [hp_X]/mL BENZOIC ACID - 10 [hp_X]/mL BERBERIS VULGARIS ROOT BARK - 4 [hp_X]/mL BOS TAURUS HYPOTHALAMUS - 12 [hp_X]/mL BRYONIA ALBA ROOT - 12 [hp_X]/mL CHONDRODENDRON TOMENTOSUM ROOT - 10 [hp_X]/mL EUTROCHIUM PURPUREUM ROOT - 12 [hp_X]/mL HERRING SPERM DNA - 12 [hp_X]/mL HYDRANGEA ARBORESCENS ROOT - 4 [hp_X]/mL MERCURIC CHLORIDE - 12 [hp_X]/mL Load more... PETROSELINUM CRISPUM - 4 [hp_X]/mL RUBIA TINCTORUM ROOT - 6 [hp_X]/mL SARSAPARILLA - 4 [hp_X]/mL SOLIDAGO VIRGAUREA FLOWERING TOP - 4 [hp_X]/mL SUS SCROFA ADRENAL GLAND - 9 [hp_X]/mL SUS SCROFA PANCREAS - 9 [hp_X]/mL SUS SCROFA PITUITARY GLAND - 12 [hp_X]/mL THYROID, BOVINE - 9 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	06 Jun, 2014
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	10 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Energetix Corp
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0364578040715
UPC stands for Universal Product Code.
NUI:	N0000175806 N0000175807
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	3M5V3D1X36 8SKN0B0MIM 1TH8Q20J0U S6G2NLH4Y7 T7J046YI2B 395A3P448Z 0VYG5PVN5Q 51FI676N6F SFK828Q2DE 53GH7MZT1R Load more... 1WZA4Y92EX 0SVP95L23G 2H1576D5WG 5405K23S50 398IYQ16YV 9Y3J3362RY L0PFEMQ1DT MN18OTN73W
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class MOA:	Ammonium Ion Binding Activity [MoA]
Mechanism of action of the drug—molecular, subcellular, or cellular functional activity—of the drug’s established pharmacologic class. Takes the form of the mechanism of action, followed by `[MoA]` (such as `Calcium Channel Antagonists [MoA]` or `Tumor Necrosis Factor Receptor Blocking Activity [MoA]`.
Pharmacologic Class EPC:	Nitrogen Binding Agent [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class:	Ammonium Ion Binding Activity [MoA] Nitrogen Binding Agent [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
64578-0103-1	59.1 mL in 1 BOTTLE, DROPPER (64578-0103-1)	13 Jul, 2017	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Renapath

Benzoicum Acidum & more..

Liquid
Energetix Corp
NDC: 64578-0103

Purpose:

Purpose temporary relief of copious or diminished urination, occasional swelling in extremities.

Product Elements:

Renapath benzoicum acidum, berberis vulgaris, bryonia, dna, eupatorium purpureum, glandula suprarenalis suis, hydrangea arborescens, hypothalamus, mercurius corrosivus, pancreas suis, pareira brava, petroselinum sativum, pituitarum posterium, rubia tinctorum, sarsaparilla, solidago virgaurea, thyroidinum (bovine), uva-ursi benzoic acid benzoic acid berberis vulgaris root bark berberis vulgaris root bark bryonia alba root bryonia alba root herring sperm dna herring sperm dna eutrochium purpureum root eupatorium purpureum root sus scrofa adrenal gland sus scrofa adrenal gland hydrangea arborescens root hydrangea arborescens root bos taurus hypothalamus bos taurus hypothalamus mercuric chloride mercuric cation sus scrofa pancreas sus scrofa pancreas chondrodendron tomentosum root chondrodendron tomentosum root petroselinum crispum petroselinum crispum sus scrofa pituitary gland sus scrofa pituitary gland rubia tinctorum root rubia tinctorum root sarsaparilla sarsaparilla solidago virgaurea flowering top solidago virgaurea flowering top thyroid, bovine thyroid, bovine arctostaphylos uva-ursi leaf arctostaphylos uva-ursi leaf water glycerin alcohol

Indications and Usage:

Uses temporary relief of copious or diminished urination, occasional swelling in extremities.

Warnings:

Warnings in case of overdose, get medical help or contact a poison control center right away. if pregnant or breast feeding, ask a health professional before use. keep out of reach of children.

Dosage and Administration:

Directions take 30 drops orally twice daily or as directed by a healthcare professional. consult a physician for use in children under 12 years of age or if symptoms worsen or persist.

Package Label Principal Display Panel:

Energetix renapath homeopathic remedy copious or diminished urination, occasional swelling in extremities. 2 fl oz (59.1 ml) 2 oz. bottle label purpose temporary relief of copious or diminished urination, occasional swelling in extremities.

Further Questions:

Distributed by energetix corp. dahlonega, ga 30533 questions? 800.990.7085 www.goenergetix.com

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.